382 results
The first rigorous randomized trial to evaluate platelet-rich plasma for ankle osteoarthritis failed to demonstrate efficacy. Read more about this trial in this EBM Focus article.
The EBM Focus team at DynaMed® discusses a large cohort study evaluating risk of myocarditis after COVID vaccination.
Mixed evidence for procalcitonin to identify bacterial infections contributes to the confusion over whether it is useful. Read about a new pragmatic trial evaluating procalcitonin with or without point-of-care ultrasound for suspected pneumonia.
Will Estimating GFR Without Adjusting for Race Help to Reduce Racial Bias in Chronic Kidney Disease?
Estimating glomerular filtration rate (GFR) includes adjusting for race, leading to disparities in care of Black patients with kidney disease. The team at DynaMed® examines this racial bias.
KidsCareEverywhere Founder and Executive Director Ron Dieckmann shares stories around the organization’s work in Nepal, providing essential health care training to doctors at a not-for-profit medical school.
Explore how Policy Manager from MCN Healthcare and Dynamic Health from EBSCO have come together to offer a complete and streamlined policy and procedure process.
In this EBM Focus article, DynaMed® editors discuss the impressive effects of semaglutide on weight loss and the limitations of this new study.
With millions of people around the world vaccinated with an mRNA-based vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
Explore GIDEON’s user-centric approach to transforming its interface to meet the diverse needs of modern clinical and academic users. Read a first-hand account from GIDEON Director, Product Development and Marketing, Kristina Symes.
Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. Read about this new therapy from the Infectious Disease team at DynaMed®.